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Abstract
Background: Cholesterol uptake and transportation during the feeding larval stages are critical processes in insects 
because they are auxotrophic for exogenous (dietary) cholesterol. The midgut is the main site for cholesterol uptake in 
many insects. However, the molecular mechanism by which dietary cholesterol is digested and absorbed within the 
midgut and then released into the hemolymph for transportation to utilization or storage sites is poorly understood. 
Sterol carrier proteins (SCP), non-specific lipid transfer proteins, have been speculated to be involved in intracellular 
cholesterol transfer and metabolism in vertebrates. Based on the high degree of homology in the conserved sterol 
transfer domain to rat and human SCP-2, it is supposed that insect SCP-2 has a parallel function to vertebrate SCP-2.
Results: We identified the Manduca sexta sterol carrier protein-x and the sterol carrier protein-2 (MsSCP-x/SCP-2) gene 
from the larval fat body and the midgut cDNAs. The MsSCP-x/SCP-2 protein has a high degree of homology in the SCP-
2 domain to other insects' SCP-2. Transcripts of MsSCP-2 were detected at high levels in the midgut and the fat body of 
M. sexta during the larval stages. Recombinant MsSCP-2 bound to NBD-cholesterol with high affinity, which was 
suppressed by sterol carrier protein-2 inhibitors.
Conclusions: The results suggest that MsSCP-2 may function as a lipid carrier protein in vivo, and targeting insect SCP-
2 may be a viable approach for the development of new insecticides.
Background
In insects, cholesterol is required as a structural compo-
nent of cellular membranes and as a precursor for the
insect molting hormone (ecdysone). However, insects
lack several enzymes in the cholesterol biosynthesis path-
way [1], which makes them auxotrophic for exogenous
(dietary) cholesterol for satisfactory growth, development
and reproduction [2-4]. Therefore, cholesterol uptake
and transportation are critical for their survival. Uptake
of cholesterol involves intracellular transfer and intercel-
lular transportation. Intracellular cholesterol transfer
enables the redistribution of cholesterol within a cell, and
intercellular transport is needed for the distribution of
cholesterol between cells. It is very well documented that
lipophorin (Lp) and lipid transport particles (LTPs) are
responsible for the intercellular transportation of choles-
terol and lipids in insects [5-7].
Cholesterol is highly hydrophobic with solubility of ~10
n M  i n  w a t e r  a t  r o o m  t e m p e r a t u r e  [ 8 ] ,  c a n  b e  e a s i l y
inserted into the lipid bilayer and has a fast flip-flop rate
(t1/2 = 1-2 minutes) within the lipid bilayer [9]. Diffusion
of cholesterol into the lipid bilayer can happen readily,
and an aqueous diffusion model has been proposed to
account for some of the cholesterol uptake by cells [10].
However, the desorption of membrane-bound cholesterol
is slow without the aid of a carrier protein [10,11] to
enhance the desorption of membrane-bound cholesterol
through the collision with membrane-bound cholesterol
[12]. In vertebrates, sterol carrier protein-2 increases the
rate of cholesterol transfer between membrane structures
from t1/2 = 4 days to t1/2 = 7-15 minutes in vitro [11], dem-
onstrating the potential of lipid carrier proteins to
enhance cellular lipid uptake.
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Insect cells do not transfer cholesterol between the
midgut and the fat body via receptor mediated endocyto-
sis of Lp. The diffusion of cholesterol from Lp to target
cell membranes is thought to be the main mechanism for
the transport of cholesterol to cells [13]. Moreover, Lp is
the only apolipoprotein found in insects and Lp is not
synthesized in the midgut [14,15], which excludes the
possibility of efflux of absorbed lipids from the midgut
into the hemolymph via exocytosis of apolipoprotein/
lipid vehicles [7,16]. Therefore, nonvesicular transport of
intracellular cholesterol may be important in insect cellu-
lar cholesterol uptake via intracellular sterol carrier pro-
tein(s) to aid the desorption of membrane-bound
cholesterol and the delivery of the cholesterol within the
cytosol.
Little is known about the protein(s) involved in the
intracellular transfer of cholesterol in insects. Several
insect intracellular sterol carrier protein genes have been
identified such as the sterol carrier protein-x [17-19], the
sterol carrier protein-2 [20], and the steroid acute regula-
tor protein (StAR)-related lipid transfer protein [21,22].
In most cases, the function of those insect intracellular
sterol carrier proteins is deduced from the temporal and
spatial expression profiles and from the known function
of their vertebrate homologs.
G e n o m i c  s e q u e n c e  d a t a  s h o w  t h a t  i n s e c t s  m a y  h a v e
multiple copies of sterol carrier protein-2 (SCP-2)-like
proteins [18,23,24], in contrast to the single copy of the
SCP-x/SCP-2 gene in vertebrates [25,26] and in the silk-
worm,  B. mori [27]. SCP-x belongs to the SCP-2 gene
family, which includes SCP-2, SCP-x, 17β-hydroxysteroid
dehydrogenase IV, UNC-24, Metallo-β-lactomase and
stomatin [26,28]. In vertebrates, the SCP-x/SCP-2 gene
has two initiation sites for coding proteins. One site codes
for SCP-x which is post-translationally cleaved into 2/3-
oxoacyl-CoA thiolase and SCP-2. A second site codes for
SCP-2. Both SCP-x and SCP-2 share a common SCP-2 C-
terminus. Increasingly, data suggest that 3-oxoacyl-CoA
thiolase is involved in the oxidation of branched chain
fatty acids and SCP-2 is involved in the transfer of lipids
[29,30]. Whether insect SCP-2 and SCP-2-like proteins
have similar or divergent functions is unknown. Some
insect SCP-2 and SCP-2-like proteins lack the peroxi-
some targeting sequence at the C-termini, suggesting that
they are cytosolic proteins [23,31]. AeSCP-2, an Aedes
aegypti SCP-2 protein which is not produced from the
SCP-x gene, binds to both cholesterol [20] and fatty acid
[32], which is consistent with the broad spectrum of lipid
ligands of the vertebrate SCP-2. Over-expression or
knockdown of AeSCP-2 gene expression affects choles-
terol uptake in vivo [23,31,33]. Chemical inhibitors of
AeSCP-2 suppress cholesterol uptake in cultured cells
from Aedes aegypti and Manduca sexta, indicating that
M. sexta has a protein homologous to AeSCP-2 [34]. The
tobacco hornworm, Manduca sexta, has been one of the
primary experimental insect model systems for sterol
metabolism studies [35]. Studies using M. sexta have con-
tributed to a broad picture of lipid metabolism and have
revealed that cholesterol is transported from the midgut
to the fat body via lipophorin (Lp) in the hemolymph in
the free form, and absorbed cholesterol is stored as cho-
lesterol ester
Here, we report molecular cloning and characterization
of cDNA encoding SCP-x and SCP-2 from the tobacco
hornworm (Manduca sexta), and the effect of sterol car-
rier protein-2 inhibitors (SCPIs) on cholesterol and fatty
acid uptake in M. sexta larvae. The results suggest that
MsSCP-x/SCP-2 is involved in cholesterol absorption
and transportation in insects.
Results
Molecular cloning and nucleotide sequence analysis of 
MsSCP-x/SCP-2
A PCR-based cloning strategy was used to clone the
MsSCP-x/SCP-2 gene, using cDNAs from the larval
midgut and fat body as templates. Degenerate primers
( M sSCP -CF1 a nd M sSCP -CR 1)  al low ed us t o o bta in a
cDNA fragment highly homologous to the SCP-2 domain
of BmSCP-x and SlSCP-2 (Table 1). The degenerated
primer xNF and gene specific primer CR2 produced a
cDNA fragment of about 1100 bp, which matches the 2/
3-oxoacyl-CoA thiolase domain of insect SCP-x. The 3'-
RACE using MsSCP-CF3 primer (Fig. 1) produced inde-
pendent cDNA clones of about 550 bp containing a puta-
tive translation stop site (Fig. 1). Additional gene specific
primers (MsSCP-CR4: 5'-TGG CAA GGT GCA CCT
CTG-3' and MsSCP-CR3: 5'-AGA ACT AGA ACG GGA
CCT TC-3') derived from partial MsSCP-x cDNA
sequence were synthesized and used for the 5'-RACE to
obtain the 5'-ends of the cDNA. The 5'-RACE using CR4
primer produced cDNA clones of 553 bp containing a
putative translation start site at position 39 (Fig. 1). All
results taken together indicate that a putative full-length
MsSCP-x/SCP-2 gene spans a total of 1918 bps and
encodes a protein of 536 amino acids (GQ869536). Inter-
estingly, 6 independent cDNA clones from the CR3
primer 5'-RACE had 46 bp sequences at the 5'-end diver-
gent from the MsSCP-x (Fig. 1 gray colored shaded
sequence), suggesting that the MsSCP-2 transcript
(GQ869537) may be made from alternative splicing or an
alternative initiation site. The deduced amino acid
sequence of the coding region showed high similarity to
members of the SCP-2 gene family in other insect species
(Table 1). The SCP-2 domain of Manduca  SCP-x has
amino acid sequence identities of 97%, 93%, 79%, 69%,
and 69% with Bombyx mori, Spodoptera littoralis, Aedes
aegypti, Apis melifera, and Drosophila melanogaster,
respectively (Table 1). The MsSCP-x/SCP-2 gene encodesKim and Lan BMC Physiology 2010, 10:9
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the SCP-x protein with much higher homology to
BmSCP-x and SlSCP-x than the Dipteran SCP-x such as
AeSCP-x and DmSCP-x (Table 1).
Tissue and stage expression profiles of MsSCP-x/SCP-2
The transcription profiles of MsSCP-2 in different tissues
and stages were determined by semi-quantitative RT-
PCR. The MsSCP-2 mRNA level was significantly higher
in the midgut and fat body in feeding larvae (Fig. 2A,
upper panel for midgut lanes A-D). MsSCP-2 was
strongly expressed throughout the examined larval stages
and decreased slightly in the wandering and pupal stages
(Fig. 2A, upper panel for midgut lane E-F). In the fat
body, there was a transient increase in MsSCP-2 tran-
scripts at the end and beginning of each instar (Fig. 2A,
upper panel for fat body lanes B-C). Low levels of
MsSCP-2 mRNA were detected in the hemolymph,
hindgut, epidermis and muscle (Fig. 2A). However, prim-
ers corresponding to the 2/3-oxoacyl-CoA thiolase
domain detected MsSCP-x mRNA at moderate and high
levels in all tissues except the midgut (Fig. 2A, lower
panel for midgut lanes A-F). Data from RT-PCRs showed
that the transcription of SCP-x and SCP-2 mRNAs from
the MsSCP-x/SCP-2 gene is regulated differently in dif-
ferent tissues. MsSCP-2 mRNA was the predominant
transcript from this gene in the midgut during the feed-
ing stage (Fig. 2A, midgut, lanes A-D). In the midgut, the
levels of MsSCP-2 transcript increased during the 5th lar-
val instar without any increase in the level of MsSCP-x
transcript (Fig. 2A, midgut, lanes C-D). This result
implies that the MsSCP-x/SCP-2 gene might produce two
transcripts: SCP-x mRNA and SCP-2 mRNA, which is
similar to the human SCP-x/SCP-2 gene and other lepi-
dopteran SCP-x/SCP-2, BmSCP-x/BmSCP-2 [26,27].
Western blotting analysis was performed to investigate
the existence of an SCP-2 homolog in tissues from Day 3
4th  instars using affinity-purified anti-SCP-2 domain
polyclonal antibodies of mosquito SCP-x, AeSCP-x [31].
Figure 3 shows that a protein similar to the molecular
weight of 14 kDa (the predicated molecular weight of
MsSCP-2 is 14,134 Da) was detected by anti-AeSCP-x
antibodies, suggesting that M. sexta may have a SCP-2
analog. Tissues expressing MsSCP-2 in M. sexta at high
levels were the midgut and fat body, which was consistent
with the results of RT-PCR (Fig. 2A, lane B). Trace
amounts of SCP-2 were also detected in the hindgut and
epidermis (Fig. 2B, lane 4 and 7). A band of about 58 kDa
protein in the hemolymph was detected by the anti-SCP-
2 domain antibody, which was presumably the full-length
MsSCP-x. In both the hindgut and epidermis, the pre-
dominant transcript from the MsSCP-x/SCP-2 gene was
the SCP-x mRNA (Fig. 2A, lane B), whereas the MsSCP-2
protein was the only detectable product of the MsSCP-x/
2 gene (Fig. 2B, lanes 4 and 7). The results indicate that
the full length MsSCP-x protein was proteolytically
cleaved to produce the SCP-2 domain protein in those
tissues. The MsSCP-x protein was not processed to pro-
duce MsSCP-2 in the hemocytes due to the prominent
SCP-x band and the lack of the MsSCP-2 band (Fig. 2B,
lane 2).
Ligand and SCPIs binding in MsSCP-2
The binding affinity (Kd) of recombinant MsSCP-2 to the
cholesterol analog was determined using an NBD-choles-
terol binding assay. As shown in Figure 4, increasing the
concentrations of MsSCP-2 (over the range 1 nM~10
μM) while maintaining the concentration of NBD-choles-
terol constant (1 μM) resulted in increased fluorescence
emission of NBD-cholesterol. Analysis of the binding
curve using the one site binding non-linear regression
model in GraphPad PRISM software (Ver. 4.0) yielded
high binding affinity for both MsSCP-2 and AeSCP-2
(positive control). Aedes aegypti SCP-2 (AeSCP-2) is not
transcribed from the SCP-x gene [18] but belongs to the
SCP-2 gene family, and has been shown to have high
affinity to cholesterol [20]. The binding affinity (Kd) was
1.86 × 10-6 M (R2 = 0.9039) for MsSCP-2 and 8.2 × 10-7 M
(R2 = 0.9231) for AeSCP-2, respectively. However, the
GST (negative control) showed little binding to NBD-
cholesterol (Fig. 3, GST). Although Scatchard plots are
useful for visualizing data, they are not the most accurate
estimation. In this experiment, we used the one site bind-
Table 1: Identities of deduced amino acid sequences of the MsSCP-x/SCP-2 (Accession# GQ869536 and GQ869537) to the 
proteins of insect SCP-x gene in other insect species
SCP-x 2/3-oxoacyl-CoA-thiolase domain SCP-2 domain
Bombyx mori 91.79% 90.48% 96.55%
Spodoptera littoralis 89.37% 88.33% 93.10%
Drosophila melanogaster 61.88% 60.57% 68.64%
Apis melifera 60.81% 59.29% 68.97%
Aedes aegypti 64.51% 60.71% 78.45%
Aedes aegypti (AeSCP-2) 23.47%Kim and Lan BMC Physiology 2010, 10:9
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Figure 1 The nucleotide sequences of MsSCP-x (GQ869536) and MsSCP-2 (GQ869537) cDNAs. The start and stop codons are bold/underlined. 
The divergent 5' UTR sequence in MsSCP-2 is in shaded in gray color. Potential intron/exon splicing site in the MsSCP-2 5'UTR is in bold lower case 
letter. Sequences of forward and reverse primers used in cloning and RT-PCR are aligned under the cDNA sequence with arrows indicating the orien-
tation for PCR reactions.
MsSCP-x   gtcttctacttgaggtatagtaataattattttaccaaaATGCCTAGAAAAGTTTATGTTGTTGGCGTCGGAATGACGAA 
            
MsSCP-x   CTTCATCAAGCCGTCGACTGGAGGCGACTATCCCGATTTCGGCAAGGAGGCTGTGCTGGCCGCACTGGCCGACGCGCGGA 
 
MsSCP-x   TCAAATACGACGATGTGCAGCAAGCTATCTGCGGCTATGTGTTCGGGGACTCTACCTGCGGCCAGCGCGTGCTGTACCAG 
 
MsSCP-x   GTGGGCATGACCGGCATCCCCATCTACAACGTGAACAACAACTGCTCCACCGGCTCCAACGCCCTGTTCCTCGGCAAACA 
 
MsSCP-x   ACTTATCGAGGGCGGCATTTGTGACGTCGCGCTGGCTGTAGGTTTCGAGAAAATGGCGCCCGGAGCGCTCAGCGCCGGAC 
 
MsSCP-x   ACTTCGACGATAGAACTAACCCCCTAGACAGACACACTCTCAAAATGGGAGACATCACTGAACTAACCGGAGCCCCGATC 
            TTCAACGACAGAACCAACCC(xNF)--> 
MsSCP-x   ACTGCCCAATACTTTGGTAACGCGGCTATTGAACACATGAAGAAATACGGCACGACAGAGGTGCACCTTGCCAAGATCGC 
                                                         <--GTCTCCACGTGGAACGGT(CR4) 
MsSCP-x   TGCTAAAAATCACCGTCACGGCTGCAAGAACCCTCGCGCTCAAAGCAAGAGGGAGTACACAGTTGAGGAGATCTTAAACT 
 
MsSCP-x   CCAGAAAGATTTACGGTCCTCTCACTAAGCTTGAGTGCTGCCCAACTAGTGACGGAGCTGGTGCCGCAGTACTCATGTCA 
 
MsSCP-x   GAGGAGGCTGTCAAACGCTATGGACTACAAGACAAAGCTGTAGAGATCATTGGTATGGAGATGGCGACAGACACACCAGC 
 
MsSCP-x   TGTTTTCCAAGAAAACAGTCTCATGAAGGTTGCGGGTTATGATATGACGGCTCTTGCTGCTAAACGGATTTACCAAAAGA 
 
MsSCP-x   CTGGTGTCAACCCTATGCAAGTAGATGTGGTAGAGCTCCATGATTGCTTTGCTGCGAATGAGATGATTACTTATGAAGGC 
 
MsSCP-x   CTCCAACTCTGTGGTGAGGGACAGGCCGGCAAGTTCATTGATGCAGGAGACAATACGTATGGAGGCAGGGTTGTGGTTAA 
 
MsSCP-x   TCCGAGTGGTGGTCTGATTGCGAAGGGGCACCCTCTGGGAGCGACTGGGCTGGCGCAGTGCGCCGAGCTCGTGTGGCAGT 
MsSCP-2                                                              gagttctaattcaacttttga 
 
MsSCP-x   TGAGAGGCGAGGCTGGGAACAGACAGGTGCCGCGCGCGAGAATAGCTCTGCAACACAACCTGGGCCTGGGCGGAGCCGTA 
MsSCP-2   gcagtgacttacgctgtacttttctggtgccgcgcgcgagaatagctctgcaacacaacctgggcctgggcggagccgta 
 
MsSCP-x   GTCATCACGATGTACAGGAAAGGATTCACCAATGTCAGCCCCAACAACGTGGCCGCCATCGCTAGCAGCCCCGAGGAGTT 
MsSCP-2   gtcatcacgATGTACAGGAAAGGATTCACCAATGTCAGCCCCAACAACGTGGCCGCCATCGCTAGCAGCCCCGAGGAGTT 
 
MsSCP-x   CAAAGTGTACAAATACATGAAGATCCTCGAGGAGGCGATGCAGACCGACGAGGACAATCTCATCGAGAAGGTGCGCGGCA 
MsSCP-2   CAAAGTGTACAAATACATGAAGATCCTCGAGGAGGCGATGCAGACCGACGAGGACAATCTCATCGAGAAGGTGCGCGGCA 
                   CAAATACATGAAGATCCTTGA(CF1)--> 
MsSCP-x   TCTACGGGTTCAAGGTCAGGAATGGACCCAACGGTGCTGAGGGTTACTGGGTCATTAATGCCAAGGAAGGCAAAGGGAAA 
MsSCP-2   TCTACGGGTTCAAGGTCAGGAATGGACCCAACGGTGCTGAGGGTTACTGGGTCATTAATGCCAAGGAAGGCAAAGGGAAA 
       TACGGGTTCAAGGTCAGGAATGGA(CF2)--> 
MsSCP-x   GTCACCTACAATGGCAGCGAGAAACCCGACGTCACTTTCACAGTGAGCGATGAAGATGTCGCTGATCTGATCTCCGGCAA 
MsSCP-2   GTCACCTACAATGGCAGCGAGAAACCCGACGTCACTTTCACAGTGAGCGATGAAGATGTCGCTGATCTGATCTCCGGCAA 
                               AAACCCGACGTCACTTTCAC(CF3)--> 
MsSCP-x   GCTGAACCCGCAGAAGGCGTTCTTCCAGGGCAAGATCAAGATCCAGGGCAACATGGGCCTGGCGATGAAGCTCACGGACC 
MsSCP-2   GCTGAACCCGCAGAAGGCGTTCTTCCAGGGCAAGATCAAGATCCAGGGCAACATGGGCCTGGCGATGAAGCTCACGGACC 
                       <--(CR3)GAAGGTCCCGTTCTAGTTCTAGGTC 
                              <--(CR2)CCGTTCTAGTTCTAGGTCCCGTT 
MsSCP-x   TGCAGAGACAAGCCGCTGGCAGGATTGACACCATCCGCTCCAAACTGTAGactccaaaccggttgcgaactggttgtaat 
MsSCP-2   TGCAGAGACAAGCCGCTGGCAGGATTGACACCATCCGCTCCAAACTGTAGactccaaaccggttgcgaactggttgtaat 
 <--(CR1)GTTCGGCGGCCGTCCTAGCT 
MsSCP-x   gtaatttggttacggaacgcggtgtgggcatctttatacttaatcgcacatgaaatagttacatcggcaacctgttggtg 
MsSCP-2   gtaatttggttacggaacgcggtgtgggcatctttatacttaatcgcacatgaaatagttacatcggcaacctgttggtg 
 
MsSCP-x   tttttataatgtaaacataaaacaaggtcacacacgtttgggagtggacgtgctataagtgttttgtatgtaagtgtaaa 
MsSCP-2   tttttataatgtaaacataaaacaaggtcacacacgtttgggagtggacgtgctataagtgttttgtatgtaagtgtaaa 
 
MsSCP-x   tcgttttatattgtataatatatttatgtaatcattccaaatgtttattcatatttgttaataaaatattttttatatga 
MsSCP-2   tcgttttatattgtataatatatttatgtaatcattccaaatgtttattcatatttgttaataaaatattttttatatga 
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ing non-linear regression model, since the linear transfor-
mation of Scatchard plots distorts the experimental error.
The inhibitory effect of SCPIs on cholesterol binding to
MsSCP-2 was measured using NBD-cholesterol competi-
tion assays. SCPI-1 and SCPI-2 reduced NBD-cholesterol
binding to MsSCP-2 in a concentration-dependent fash-
ion (Fig. 4). AeSCP-2 and GST proteins were used as pos-
itive and negative controls, respectively. SCPIs inhibited
the binding of NBD-cholesterol to both MsSCP-2 and
AeSCP-2. However, SCPIs showed no effect on the bind-
ing of NBD-cholesterol and GST, which is a non-binding
protein to lipid species (Fig. 4). The 50% maximal effec-
tive concentration (EC50) of SCPI-1 and SCPI-2 to block
NBD-cholesterol-MsSCP-2 binding was determined
Figure 2 Expression of MsSCP-x and MsSCP-2. (A) The semi-quanti-
tative RT-PCR shows that mRNA levels from different tissues at different 
developmental stages of M. sexta. Lane A: Day 1-4th instar; lane B: Day 
3-4th instar; lane C: Day 1-5th instar; lane D: Day 4-5th instar; lane E: Day 
1-wandering stage; lane F: Day 1-pupal stage. The Manduca rpS3 gene 
was used as internal standard for the RT-PCR. Only 30 cycles of PCR 
were performed to avoid saturating the signals. (B). Proteins from dif-
ferent tissues of Day 3-4th instar M. sexta larva were loaded 20 μg per 
lane except lane 8 that only had 10 ng purified recombinant MsSCP-2. 
Protein was analyzed on 4-20% gradient SDS PAGE. Lane 1: protein size 
marker; Lane 2: hemolymph; Lane 3: midgut; Lane 4: hindgut; Lane 5: 
fat body; Lane 6: muscle; Lane 7: epidermis; Lane 8: recombinant MsS-
CP-2.
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Figure 3 NBD-cholesterol binding assays for MsSCP-2, AeSCP-2 
and GST. The data were processed using PRISM4.0 software. RFU = 
Relative fluorescence unit.
0.1 1 10 100
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
MsSCP-2
AeSCP-2
GST
Kd=0.82
Kd=1.86
Protein concentrations ( M)
R
F
U
Figure 4 NBD-cholesterol and SCPIs competition binding assays 
to MsSCP-2. Assays for NBD-cholesterol and sterol carrier protein-2 in-
hibitors (SCPIs; A: SCPI-1; B: SCPI-2) competitive binding to MsSCP-2. 
The background NBD-cholesterol fluorescence (NBD-cholesterol alone 
in the reaction buffer) was deducted from each assay. Shown are net 
changes in NBD-cholesterol fluorescence in intensity (RFU = Relative 
fluorescence unit) in the presence of increasing concentrations of each 
SCPI. GST and AeSCP-2 were used as negative and positive controls, re-
spectively. The data were processed using PRISM4.0 software.
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using the one site competition binding, non-linear
regression model in GraphPad PRISM® software version
4.0 (GraphPad Software Inc., San Diego, CA). The EC50s
of SCPI-1 were 2.2 μM (R2 = 0.9531) and 0.9 μM (R2 =
0.9801) for MsSCP-2 and AeSCP-2, respectively (Fig. 4A).
The EC50s of SCPI-2 were 0.9 μM (R2 = 0.8832) and 0.8
μM (R2 = 0.9773) for MsSCP-2 and AeSCP-2, respectively
(Fig. 4B). The result suggests that SCPIs have high bind-
ing affinities to insect SCP-2s and are able to compete
with NBD-cholesterol for binding to MsSCP-2 and
AeSCP-2. The result also indicates that SCPI-2 may be
more effective in inhibiting MsSCP-2's function than that
of SCPI-1 (Fig. 4), which is consistent with the observa-
tion in the mosquito AeSCP-2 [34]. Whether the differ-
ences in the EC50  values of SCPI-1 and SCPI-2 in
inhibiting cholesterol binding to MsSCP-2 result in dif-
ferent biological effects will be described later.
Effects of SCPIs on lipid uptake in M. sexta
To determine whether MsSCP-2 is involved in cholesterol
uptake in vivo, we investigated the effects of SCPIs on
cholesterol absorption in gate II day 3 4th instar larvae
when MsSCP-2 expression was high in both the midgut
and fat body (Fig. 2A, lane B). Larvae were fasted for 2
hours, then were fed 0.1 g of diet containing [1,2-3H]-
cholesterol and SCPI-1 and SCPI-2 at LD50 dosages [34].
Tracking the ingested [1,2-3H (N)]-cholesterol in Schisto-
cerca gregaria showed that insects appear not to alter the
3H label on the [1,2-3H]-cholesterol  in vivo, therefore,
measuring the amount of [1,2-3H]-cholesterol can be
used directly as an indication of cholesterol uptake [36].
Moreover, Manduca sexta larvae absorb free [3H]-choles-
terol readily with little modification of the absorbed [1,2-
3H]-cholesterol [37].
The lipophorin in the hemolymph uploads absorbed
dietary lipids at the basal side of the midgut and trans-
ports the cholesterol to the fat body for storage [14,16]. It
was hypothesized that cytosolic lipid transport proteins
in the midgut transfer absorbed dietary lipids toward the
basal side of the epithelium where lipophorin picks up the
lipids [7,16]. We speculated that MsSCP-2 could be one
of the midgut sterol carrier proteins that aid the uptake of
cholesterol because MsSCP-2 was expressed at high lev-
els in the midgut and fat body (Fig. 2A and 2B) and
MsSCP-2 bound to a cholesterol analog (Fig. 2B). To
determine whether the inhibition of MsSCP-2 function
would affect cholesterol uptake from the diet into the
midgut,  [3H]-cholesterol in midgut tissue was measured
at different time points after feeding. In the midgut tis-
sue, [3H]-cholesterol content decreased significantly in
the controls between 2 and 6 hours post feeding (p  =
0.003), indicating the clearance of absorbed [3H]-choles-
terol over time from the midgut tissue (Fig. 5A, control).
The result is consistent with the previous report of a slow
but steady clearance of [3H]-cholesterol from the midgut
within 6 hours post feeding [37]. In SCPI-1 treated larvae
at the 2 hour time point, the total [3H]-cholesterol in the
midgut tissue was slightly lower than that of the control
group, whereas, the SCPI-2-treated group had signifi-
Figure 5 Effects of SCPIs on [1,2-3H (N)]-cholesterol uptake in M. 
sexta Day 3 4th instar larvae. (A) The midgut. (B) The hemolymph. (C) 
The fat body. Values = mean ± S.D. (N = 2). Details of the label/chase 
experiment are provided in the "Materials and Methods". The same let-
ters above the bars in each time point represent that the mean values 
did not differ from other group of the same time point significantly (p 
> 0.05) in paired t-tests.
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cantly much less (p = 0.01; 43.18% of the controls) labeled
cholesterol (Fig. 5A, 2 hour time point). At 6 hours post
feeding, there was a significant decrease of [3H]-choles-
terol in the midgut in both the control and SCPI-1-
treated groups (p = 0.04), indicating that absorbed cho-
lesterol was likely transported out of the midgut tissues
(Fig. 5A, 4 hour time point). There was no significant
change in the levels of labeled cholesterol 2 to 6 hours
post feeding in SCPI-2-treated groups (Fig. 5A, 4 hour
time point), which suggests that there was little transfer
of absorbed cholesterol. Over the observed time period,
the total amount of [3H]-cholesterol in the midgut tissue
was significantly lower in SCPI-1 and SCPI-2-treated lar-
vae than in the controls (F1,6 = 8.627, p = 0.026 and F1,6 =
51.47, p = 0.0004, respectively). The amount of [3H]-cho-
lesterol in the midgut 2 to 6 hours post feeding was
688640.7, 555098.9, and 367836.9 DMP/mg protein for
the control, SCPI-1-, and SCPI-2-treated groups, respec-
tively (Fig. 5A). The results imply that the uptake of [3H]-
cholesterol into the midgut tissue in SCPI-treated larvae
was less efficient than in the controls. SCPI-2 was more
effective in inhibiting cholesterol binding to MsSCP-2
than that of SCPI-1 (Fig. 4). SCPI-2 had severer effects on
MsSCP-2's function in vivo resulting in a 46% greater
reduction in [3H]-cholesterol uptake/transport than the
SCPI-1-treatment (F1,6 = 19.55, p = 0.0045) in the midgut
tissue (Fig 5A, SCPI-1 and SCPI-2).
To determine whether the inhibition of MsSCP-2 func-
tion would affect cholesterol transfer from the midgut to
the hemolymph, [3H]-cholesterol in the hemolymph was
measured at different time points after the feeding. In the
hemolymph, constant high levels of [3H]-cholesterol were
observed over the time period in the control group (Fig.
5B), which is consistent with the observation that hemo-
lymph [3H]-cholesterol levels in the label/chase experi-
ments remains steady 4-18 hours post feeding [38].
However, the hemolymph [3H]-cholesterol levels were
significantly lower (F1,6 = 38.72, p  = 0.0008 and F1,6 =
33.15, p = 0.0012 for SCPI-1 and SCPI-2, respectively) in
the SCPI-treated groups at all post feeding time points
(Fig. 5B, SCPI-1 and -2). The amount of hemolymph
[3H]-cholesterol at each time point was significantly
higher in control larvae than that of SCPI-1-treated lar-
vae (Fig. 5B, control and SCPI-1) whereas there were
insignificant differences at the same time point in the
amount of [3H]-cholesterol in the midgut tissue between
the controls and SCPI-1-treated larvae (Fig. 5A, control
and SCPI-1). The results indicate that the efflux of
absorbed cholesterol from the midgut into the hemo-
lymph was affected in SCPI-treated larvae, suggesting
that there was an impairment of [3H]-cholesterol trans-
port from the midgut into the hemolymph. On the other
hand, the amount of labeled cholesterol in the hemo-
lymph 2 to 6 hours post feeding was 28087.6 and 29564.4
DPM/mg protein for SCPI-1 and SCPI-2 treated larvae,
respectively (Fig. 5B), showing that the efflux of choles-
terol from the midgut into the hemolymph was similar
between SCPI-1 and SCPI-2 treated larvae even though
SCPI-2 treated larvae had significantly lower levels of
labeled cholesterol in the midgut (Fig. 5A). Therefore,
SCPI-1 and SCPI-2 had a similar effect on the efflux of
cholesterol despite the differences in their efficiency in
inhibiting cholesterol binding to MsSCP2 (Fig. 4).
The insect fat body is the site of cholesterol storage
during the feeding stage [38]. The amount of [3H]-choles-
terol increased 3-fold from 2 hours to 6 hours post feed-
ing in the fat body of the control larvae, indicating an
uptake of [3H]-cholesterol over time (Fig. 5C, control).
The results from the controls are consistent with other
studies in which ingested [3H]-cholesterol is rapidly accu-
mulated in the fat body in Manduca larvae [38]. In con-
trast, in SCPI-1 or SCPI-2 treated larvae, the
accumulation of [3H]-cholesterol in the fat body within 6
hours post feeding was significantly lower (F2,9 = 29.64, p
= 0.0001) than that of in the controls (Fig. 5C, SCPI-1 and
SCPI-2). This is consistent with the observation that the
total amount of [3H]-cholesterol is significantly lower in
the hemolymph of SCPI-treated larvae (F2,9 = 26.59, p =
0.002; Fig. 5B). The 6 hour-post feeding time represented
the accumulation of labeled cholesterol stored in the fat
body for the observed period. SCPI-1 and SCPI-2 treat-
ment suppressed cholesterol storage in M. sexta larvae
within 6 hours of treatment by 37% and 69%, respectively
(Fig. 5C, 6 hour). SCPI-2-treated larvae had significantly
less stored [3H]-cholesterol than the SCPI-1 treated lar-
vae (Fig. 5C, 6 hour) although the amount of labeled cho-
lesterol in the hemolymph in both treatments were
similar (Fig. 5B, SCPI-1 and SCPI-2). The result implies
that SCPI-2 was more effective than SCPI-1 in blocking
the uptake of cholesterol from the hemolymph into the
fat body. The results of this study provide the evidence for
the first time that SCPIs inhibit cholesterol uptake into
the midgut, reduce the efflux of absorbed cholesterol into
the hemolymph, and block the uptake of cholesterol in
the fat body in vivo in M. sexta larvae.
Vertebrate SCP-2 binds to fatty acid and cholesterol
[26]. To investigate whether MsSCP-2 is also involved in
fatty acid transport in the midgut, we fed labeled [3H]-
palmatic acid in a label/chase experiment as described
above. In the midgut tissue of the control group, there
was a significant rapid decrease (p = 0.05) in the levels of
[3H]-palmatic acid from 2 to 6 hours post feeding (Fig.
6A), indicating a very quick clearance of absorbed labeled
fatty acid in the midgut. This is consistent with the previ-
ous reports that showed rapid uptake and clearance of
free fatty acid from the midgut into the hemolymphKim and Lan BMC Physiology 2010, 10:9
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within 4 hours post feeding [37,39]. In the SCPI-treated
larvae, there was a significant reduction of [3H]-palmatic
acid levels (F2,9 = 15.15, p = 0.0013) in the midgut tissue
except at the 4 hour time point in the SCPI-2 treated
group (Fig. 6A), suggesting that there was a generalized
suppression in the uptake of free fatty acid from the
midgut lumen into the midgut tissue in SCPI-treated lar-
vae. However, there were no significant differences
between the controls and SCPI-treated larvae in the
quantity of [3H]-palmatic acid in the hemolymph (Fig.
6B) or in the fat body (Fig. 6C), implying that the clear-
ance of absorbed fatty acid from the midgut and the stor-
age of absorbed fatty acid in the fat body were not
affected by SCPI-treatment.
Discussion
There are multiple steps in the cellular uptake of lipids.
This process may be important for insects since receptor
or lipoprotein mediated endocytosis and/or exocytosis is
not involved in cellular lipid transfer [13]. Lipids can eas-
ily diffuse into the outer layer of the cytoplasm mem-
brane where they flip-flop across the membrane bilayer.
Cytosolic lipid carriers such as cytosolic fatty acid bind-
ing protein and SCP-2 desorbs the free lipids from the
cytoplasm membrane and deliver them to the storage site
or funnel them into a metabolic pathway [40,41]. The
mechanisms underlying MsSCP-2-mediated cellular cho-
lesterol uptake are unclear. AeSCP-2 is not a membrane
bound protein [31], and MsSCP-2-mediated lipid absorp-
tion is unlike membrane transporters, such as Niemann-
Pick C1-like 1 (NPC1-L1) [42]. MsSCP-2 may enhance
the desorption of membrane-bound ligand through the
collision with membrane-bound cholesterol [9], which, in
turn, may lead to a MsSCP-2-mediated cholesterol diffu-
sion into the cytosol. The SCP-2/membrane collision
model is the proposed mode for fatty acid transport by
the SCP-2 of Yarrowia lipolytica [43].
In an earlier study, sterol carrier protein-2 inhibitors
(SCPIs) were identified via high throughput screening
using recombinant AeSCP-2 [34]. AeSCP-2 is not a prod-
uct of the AeSCP-x gene [18]. However, both AeSCP-x
and AeSCP-2 belong to the SCP-2 gene family [28]. The
SCPIs inhibit ligand binding in both AeSCP-2 and the
SCP-2 domain protein of AeSCP-x, although the EC50s of
the same SCPI are higher for the SCP-2 domain protein
of AeSCP-x than for AeSCP-2 [34]. SCPIs are lethal to
both mosquito and Manduca sexta larvae [34]. It was
speculated that the Manduca sexta has a protein homolo-
gous to that of mosquito AeSCP-2, which was inhibited
by SCPIs to cause the biological effects in Manduca lar-
vae [34]. To further investigate the possible existence of
Manduca sexta SCP-2 (MsSCP-2), we identified MsSCP-
x/SCP-2 via reverse-transcriptase PCR based cloning
strategy using degenerate primers designed on the basis
of a consensus cDNA sequence within insect SCP-x/SCP-
2 genes (Fig. 1). In vertebrates, the SCP-x/SCP-2 gene
codes two proteins that share a common 13 kDa SCP-2
domain: 58 kDa SCP-x and 15 kDa pro-SCP-2, which is
post-translationally cleaved to 13 kDa SCP-2 [26].
MsSCP-X has the same domain architecture as vertebrate
SCP-x. The full-length of the MsSCP-Z/SCP-2 cDNA
encodes a protein of 536 amino acids (GQ869536). The
amino acid sequence similarities between MsSCP-2 and
Figure 6 Effects of SCPIs on [9,10-3H]-palmitic acid uptake in M. 
sexta Day 3 4th instar larvae. (A) The midgut. (B) The hemolymph. (C) 
The fat body. Values = mean ± S.D. (N = 2). Details of the label/chase 
experiment are provided in the "Materials and Methods". The same let-
ters above the bars in each time point represent that the mean values 
did not differ from other group of the same time point significantly (p 
> 0.05) in paired t-tests.
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the SCP-2 domain of SCP-x in other insect species were
high (≥60%, Table 1).
Using two pairs of primers that detect the N-terminal
2/3-oxoacyl-CoA thiolase domain and the C-terminal
SCP-2 domain, it was discovered that the transcripts for
MsSCP-x and MsSCP-2 were differentially regulated
based on the abundance of each in the same samples (Fig.
2A). The differential production of the transcripts was
most evident in the midgut and fat body, at which time
the midgut had predominantly MsSCP-2 mRNA,
whereas the fat body had a much higher level of MsSCP-x
transcript (Fig. 2A, lane A). In the cotton leafworm (S. lit-
toralis), two transcripts from a single copy of the SCP-x/
SCP-2 gene were detected [19]. However, in the silkworm
(B. mori), alternative splicing seemed to generate two
transcripts from a single copy of the SCP-x/SCP-2 gene
[27]. The first 46 bps of the 5'end UTR sequence of
MsSCP-x is divergent from the MsSCP-x 5' UTR or the
sequence corresponding to the SCP-2 domain (Fig. 1,
s h a d e d  s e q u e n c e  i n  5 '  U T R  o f  t h e  M s S C P - 2  c D N A
sequence), whereas the identical sequence in the 5' UTR
of MsSCP-2 to the SCP-2 domain of the MsSCP-x tran-
script started at the same position as the splicing site in
the B. mori SCP-x/SCP-2 gene (Fig. 1, bold letter "g" in
MsSCP-2 5' UTR; [27]). Whether the MsSCP-x/SCP-2
gene may produce two transcripts via alternative splicing
needs further investigation.
The spatial expression protein files of MsSCP-x are dif-
ferent from those described in S. littoralis and B. mori, in
which the SCP-x transcript level is higher in the midgut
and Malpighian tubules. In contrast, the MsSCP-x
mRNA levels were much lower in the midgut than in
other tissues in general (Fig. 2A). The spatial transcrip-
tion profiles of MsSCP-x and MsSCP-2 are similar to the
mRNA levels of the vertebrate SCP-2 gene. The verte-
brate SCP-x is detected essentially in all tissues, whereas
SCP-2 was in highest abundance in the liver and intestine
[26]. The MsSCP-2 transcription levels were higher in the
midgut and fat body during the feeding stage (Fig. 2A,
lanes A to D); the metabolic function of the fat body is
similar to that of the vertebrate liver and adipose tissue.
However, the insect SCP-x protein appears to be pro-
cessed post-translationally to produce two proteins: the
2/3-oxoacyl-CoA thiolase and the SCP-2 [18,19], which
would render higher protein levels of SCP-2 in tissues
transcribing SCP-x at higher levels.
The anti-SCP-2 domain of AeSCP-x antibodies recog-
nized the purified recombinant MsSCP-2 (Fig. 2B, lane 8)
and detected a similar molecular weight immune-reactive
protein in the midgut, hindgut, and fat body (Fig. 2B).
This result coincides with the fact that the insect midgut
is the main site for cholesterol and fatty acid uptake [38].
This also showed the expression pattern of MsSCP-x/
SCP-2 is similar to other mosquito SCP-x and SCP-2
genes. In Aedes aegypti, AeSCP-2 and AeSCP-x were
strongly expressed in the foregut and mostly in the
midgut during the larval feeding stages [18,20]. In Aedes
aegypti, Spodoptera littoralis and Bombyx mori, SCP-xs
had high levels of transcription in the midgut during the
last larval feeding stages [18,19,27], however, the SCP-2
domain protein is the prominent product due to post-
translational processing of the SCP-x protein in the
midgut [18,19]. Therefore, regardless of which transcript
of the SCP-x/SCP-2 gene is predominant in the midgut,
high levels of SCP-2 domain protein may be the end
result.
There was 56% less (p = 0.03) stored [3H]-cholesterol 6
hours post feeding in the fat body in SCPI-2-treated lar-
vae than for the SCPI-1-treatment (Fig. 6C, SCPI-1 and
SCPI-2). In Manduca sexta GV1 cells, SCPI-1 and SCPI-
2 at 10 μM concentrations suppressed cholesterol uptake
by 15% and 22%, respectively [34]. The relatively higher
binding affinities of SCPI-2 than that of SCPI-1 to insect
SCP-2 [34] (Fig. 4) may result in the differences in biolog-
ical effects between SCPI-1 and SCPI-2 treatments in
which SCPI-2 constantly showed higher efficacy in inhib-
iting cholesterol trafficking in vivo (Fig. 6A and 6C). The
results were consistent with the earlier observation that
SCPI-2 is more lethal than SCPI-1 to Manduca larvae
[34]. Both SCPI-1 and SCPI-2 effectively inhibited cho-
lesterol uptake (Fig. 6). There was little labeled choles-
terol detected in the feces 2 hours post feeding and a
significant increase in [3H]-cholesterol in the feces over
the observed time period in the control group (Additional
file 1), although the excretion of labeled fatty acid during
t h e  s a m e  p e r i o d  w a s  c o n s t a n t  ( A d d i t i o n a l  f i l e  2 ) .  T h e
underlying mechanism for the slower excretion of choles-
terol than that of fatty acid in feces is unknown. However,
[3H]-cholesterol levels in the feces within the 6 hour
period were 265.84% (F1,6  = 31.30, p  = 0.0014) and
369.02% (F1,6 = 11.35, p = 0.015) higher in SCPI-1- and
SCPI-2 treated larvae, respectively, than in the controls
(Additional file 1). The results indicate that unabsorbed
dietary cholesterol was excreted via feces.
Studies using the vertebrate model suggest that SCP-2
mediates cholesterol trafficking and metabolism and is
involved in fatty acid uptake [26,44]. However, it is
unclear whether insect SCP-2 has similar functions in
cholesterol and fatty acid trafficking and metabolism. We
investigated the function of MsSCP-2 in vivo using sterol
carrier protein-2 inhibitors (SCPIs) to examine the bio-
logical effect of MsSCP-2 impairment on cholesterol and
fatty acid uptake in M. sexta larvae. Inhibition of MsSCP-
2's function by SCPIs resulted in arrested growth and
development in surviving larvae, indicated by lower
weight gain over time and delayed pupation (data not
shown). When Manduca larvae were fed LC50 concentra-Kim and Lan BMC Physiology 2010, 10:9
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tions of SCPI-1 and SCPI-2 for a short time (within 6
hours, see "Methods"), there was a significant reduction
in the uptake of labeled cholesterol in the midgut and fat
b o d y  i n  S C P I - t r e a t e d  l a rv a e  c o m p a r e d  t o  t h e  c o n t r o l s
(Fig. 5A and 5C). Similar results were obtained when
NBD-cholesterol, a fluorescent cholesterol analog, was
used as the tracer for cholesterol uptake in vivo (Addi-
tional file 2). However, the effect of SCPI-treatment on
palmatic acid was limited to the suppression of uptake
into the midgut (Fig. 6A and 6C). In insects, the mecha-
nism for the uptake of lipids from the diet into the midgut
is unclear. It is hypothesized that lipids (free fatty acid
and cholesterol) may be transported into the midgut epi-
thelium via specific membrane transporters, and then
trafficked intracellularly by carrier proteins toward the
basal side of the midgut for uploading onto the Lp [7].
The efficacy of a SCPI in suppressing cholesterol absorp-
tion (Fig. 5A and 5C) seemed to correlate with its effi-
ciency in inhibiting ligand-binding in SCP-2 (Fig. 4) [34],
suggesting that intracellular transport plays a critical role
in cellular uptake of cholesterol. The fact that inhibition
of MsSCP-2's function via SCPIs did not completely abol-
ish cholesterol uptake points to the possibility that there
may be more than one class of intracellular carrier pro-
teins for cholesterol in insects. Another candidate as an
intracellular cholesterol carrier is the steroid acute regu-
lator protein (StAR)-related lipid transfer protein [21,22].
The mode of larvicidal activity of SCPIs against some
insect species, including Aedes aegypti, Anopheles gam-
biae, Culex pipiens and M. sexta is unclear [34,45]. The
relatively high binding affinities of SCPI-1 and SCPI-2 to
insect SCP-2s indicate that SCPIs may inhibit the biologi-
cal functions of SCP-2 by competing with cholesterol for
binding to SCP-2 [34]. SCPI-1 and SCPI-2 suppressed
[3H]-cholesterol efflux from the midgut to the hemo-
lymph in M. sexta larvae within 6 hours of treatment (Fig.
5B), resulting in the reduction of stored [3H]-cholesterol
by 37% and 69%, respectively (Fig. 5C). Although, SCPI-1
and SCPI-2 also suppressed [3H]-palmatic acid uptake in
the midgut (Fig. 6A), there was no evidence that SCPI-
treatment impaired the efflux of absorbed [3H]-palmatic
acid from the midgut into the hemolymph (Fig. 6B). One
plausible explanation for the lack of SCPI's effect on the
efflux of fatty acid into the hemolymph and ultimately
storage in the fat body may be the redundant function of
fatty acid binding proteins in the midgut and fat body
[46]. The results of this study provide evidence that SCPIs
inhibit cholesterol uptake/storage in insects in vivo. The
effect of SCPI-treatment on fatty acid uptake in larvae
was limited to the midgut (Fig. 6). Since insects can syn-
thesize fatty acid de novo from acetate [47,48], one possi-
ble mode of action of SCPIs' larvicidal activities is
reduction in cholesterol uptake over time resulting in a
deficiency in cholesterol that might lead to a high mortal-
ity rate in SCPI-treated Manduca larvae [34]. The likely
mechanism of SCPIs in inhibiting cholesterol absorption
is the decrease in clearance of absorbed cholesterol from
the midgut tissue (Fig. 4B), suggesting that MsSCP-2 may
be involved in the cellular trafficking of cholesterol in the
midgut.
Conclusions
In this study we tested the hypothesis that MsSCP-2 may
be involved in cholesterol uptake and intracellular trans-
portation. Our results show that Manduca sexta sterol
carrier protein-x and sterol carrier protein-2 (MsSCP-x/
S C P - 2 )  h a v e  a  h i g h  d e g r e e  o f  h o m o l o g y  i n  t h e  S C P - 2
domain to other insects' SCP-2 and recombinant MsSCP-
2 bound to NBD-cholesterol with high binding affinity.
Transcripts of MsSCP-2 were highly expressed in the lar-
val midgut and fat body. The result suggests that MsSCP-
2 may be involved in cholesterol uptake in the midgut, the
main site for cholesterol absorption, and intracellular
transportation in the fat body, the main site for choles-
terol storage. MsSCP-2 may function as a lipid carrier
protein in vivo.
We have also shown that sterol carrier protein inhibi-
tors (SCPIs) effectively reduced cholesterol uptake and
cholesterol accumulation in the midgut and in fat body.
Due to the total dependence of insects on exogenous
cholesterol, targeting insect SCP-2 may be a viable
approach for the development of new insecticides.
Methods
Chemicals
Chemicals and reagents were purchased from Sigma
(Sigma, St. Louis, MO, USA), Fisher Scientific (Pitts-
burgh, PA, USA) and ICN (Costa Mesa, CA, USA) if their
origins were not mentioned in the text. [1,2-3H (N)]-cho-
lesterol (40 Ci/mMol) and [9,10-3H]-palmitic acid (60 Ci/
mMol) were purchased from American Radiolabeled
Chemicals, Inc. (St. Louis, MO, USA). AeSCP-2 inhibi-
tors, SCPI-1 (N-4-{[4-(3,4-dichlorophenyl)-1,3-thiazol-2-
yl]amino}phenyl)aetamide hydrobromide) and SCPI-2 (8-
chloro-2-(3-methoxyphenyl)-4,4-dimethyl-4,5-dihy-
droisothiazol[5,4-c]quinoline-1(2H)-thione), were pur-
chased from ChemBridge Corporation (San Diego, CA,
USA) with at least 90% purity. NBD cholesterol was pur-
chased from Molecular probes (Eugene, OR, USA).
The tobacco hornworm, Manduca sexta 
 Manduca sexta eggs were a gift from Dr. Walter G.
Goodman, University of Wisconsin-Madison. Larvae
were fed a commercial gypsy moth wheat germ diet (ICN
Biomedicals, Irvine, CA), and reared at 25°C and 60% rel-
ative humidity, under a 16:8 (Light:Dark) cycle. Fresh
food was provided every other day. Fourth instars were
selected by observing head capsule slippage at the time ofKim and Lan BMC Physiology 2010, 10:9
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the molt from the 3rd instar and were gated by weight (>
0.35 g, but <0.54 g at 24 h 4th instar and > 0.65 g, but <0.85
g at 48 h 4th instar) [49]. Only gate II larvae were used for
each set of experiments.
RNA extraction and cDNA synthesis of the first strand
Total RNA was extracted from the Day 3 4th instar Mand-
uca sexta larvae using TRIzol (Invitrogen, USA) accord-
ing to the manufacturer's instruction. The midgut was
dissected in cold Manduca saline solution [50] under a
dissecting microscope and homogenized immediately in
1 ml TRIzol reagent. Five micrograms of each RNA sam-
ple were further purified using the TURBO DNA-free Kit
(Ambion, Austin, TX, USA). The corresponding first
strand cDNAs were reverse transcribed from 0.5 μg
DNA-free total RNA using Reverse Transcription Kit
(Invitrogen, USA). The quantity of the RNA samples was
determined by UV260 absorption with a NanoDrop™ 1000
spectrophotometer (NanoDrop products, Wilmington,
DE).
Molecular cloning of MsSCP-x/SCP-2 gene
Two degenerate primers were designed for cloning based
on the consensus partial cDNA sequence of the SCP-2
domain from Bombyx mori (BmSCP-2) and Spodoptera
littoralis (SlSCP-2). MsSCP-CF1: 5'-CAA ATA CAT GAA
GAT CCT TGA-3' and MsSCP-CR1: 5'-TCA ATC CTG
CCA GCG GCT TG-3' match to the N-terminal and the
C-terminal of the SCP-2 domain, respectively (Fig. 1).
The SMART RACE cDNA Amplification Kit (Clon-
tech, Palo Alto, CA) was used for the 5'-RACE and the 3'-
RACE with cDNAs made from the midgut of Day 3 4th
instars. The PCR products were separated on 1% agarose
gel, purified with a QIAquick Gel Extraction Kit (QIA-
GEN, Valencia, USA), cloned into pCR-Blunt II-TOPO®
blunt plasmid (Invitrogen, Carlbad, CA), transformed
into the INV 110 E. Coli strain (One Shot® competent
cells) (Invitrogen, Carlsbad, CA) and plated on LB plates
under Kanamycin selection. Plasmid minipreps of seven
clones containing inserts were made using a QiaSpin col-
umn (QIAGEN, Valencia, CA) and sequenced in an auto-
matic sequencer (ABI 377XL) using BigDye labeling
(Amersham Pharmacia Biotech AB, Uppsala, Sweden).
Another degenerate primer (xNF: 5'-TTC AAC GAC
AGA ACC AAC CC-3') designed based on the consensus
cDNA sequences of the 2/3-oxoacyl-CoA thiolase
domain from Bombyx mori (BmSCP-x) and Spodoptera
littoralis (SlSCP-x), and gene specific primers (MsSCP-
CR2: 5'-AAA CGG GAC CTA GAA CTA GAA CGG-3,
and MsSCP-CR3: 5'-AGA ACT AGA ACG GGA CCT
TC-3') derived from the partial cDNA sequence of
MsSCP-2 were used to obtain the coding region of the
MsSCP-x/SCP-2 gene (Fig. 1). Additional gene specific
primer (MsSCP-CR4: 5'-TGG CAA GGT GCA CCT
CTG-3', MsSCP-CF2: 5'-TAC GGG TTC AAG GTC
AGG AAT GGA-3', and MsSCP-CF3: 5'-AAA CCC GAC
GTC ACT TTC AC-3') derived from the coding region
was synthesized and used for the 5'-and 3'-RACE to
obtain the 5'-and 3'-end of the cDNA. All PCR reactions
for MsSCP-2 gene amplification were performed as fol-
lows: initial denaturing at 95°C for 3 minutes, followed by
30 cycles of denaturing at 94°C for 30 seconds, annealing
at 61°C for 30 seconds, and extension at 72°C for 30 sec-
onds with a final extension of 72°C for 2 minutes. The
PCR products were cloned, transformed and sequenced
as described above.
Purification of recombinant MsSCP-2
To produce recombinant MsSCP-2 (rMsSCP-2), PCR
products of the entire coding region of the MsSCP-2 gene
were cloned into the pGEX-4T-2 GST tag vector (Amer-
sham Pharmacia). PCR primers were 5'-ggctggatc-
ccCCCGAGGAGTTCAAAG TG-3' (capital letters are
coding sequence; bold letter is the first codon of the
MsSCP-2 domain; a BamHI site was incorporated for
cloning) and 5'-ccggtgaattcgaCTA  CAGTTTG-
GAGCGG-3' (capital letters are the antisense of the cod-
ing sequence; bold letter is the antisense of the stop
codon; the EcoRI site was incorporated for cloning). The
expression vector was transferred into the INV 110 E. coli
strain (One Shot® competent cells) (Invitrogen, Carlsbad,
CA) under 100 μg/ml ampicilin selection. Sequence anal-
ysis was performed to confirm that the fusion protein was
in the frame with the GST. The rMsSCP-2 expression
bacteria were incubated in 200 ml Luria-Bertani (LB)
medium with 100 μg/ml ampicilin at 37°C overnight, 50
ml overnight bacterial culture was added into 500 ml
fresh LB medium with 100 μg/ml ampicilin and grown at
37°C for 2 hours (OD600  = 0.8). Then, expression of
rMsSCP-2 was induced by the addition of isopropyl-beta-
D-thiogalactoside (IPTG) to a final concentration of 0.2
mM and the culture was incubated at 18°C for about 6
hours.
Cells from the 2.5 L LB medium were harvested by cen-
trifuge at 4000×g for 15 minutes, and then the cellular
pellets were resuspended in 30 ml of PBS (140 mM NaCl,
10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, pH 7.4)
with 5 mM DTT and 2 mM EDTA. Cells were lysed using
a sonic dismembrator (model 300, Fisher, USA). The cell
lysate was centrifuged at 20000×g for 1 hour to remove
cellular debris. The GST/rMsSCP-2 fusion protein was
purified on a GST affinity column (10 ml bed volume;
Amersham Pharmacia) and the GST tag was cleaved by
digesting with 500 units of Thrombin (Amersham Phar-
macia) in the column at 4°C overnight. Thrombin was
removed from the eluted rMsSCP-2 by passing it through
a benzamidine column (Amersham Pharmacia). Purified
rMsSCP-2 was concentrated in a Centricon YM-10Kim and Lan BMC Physiology 2010, 10:9
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device (Amicon) to 1 mg/ml in a phosphate saline buffer
(PBS), pH 7.4, stored in PBS at -80°C. Concentration of
the protein was determined using UV 280 nm absorbed
coefficiency.
Tissue and stage expression profiles of MsSCP-x/SCP-2
To investigate the transcription profiles of MsSCP-x/
SCP-2 in different tissues at different developmental
stages, total RNAs from the hemolymph (hemocytes),
midgut, hindgut, fat body, muscle and epidermis were
extracted from Manduca sexta at different stages (Day 1
4th instar, Day 3 4th instar, Day 1 5th instar, Day 4 5th instar,
wandering stage, and pupal stage) and homogenized in 1
ml TRIzol reagent (Invitrogen, USA). Genomic DNA
contamination in the 5 μg total RNA samples was treated
twice with the TURBO DNA-free™ kit (Ambion, USA)
and the samples were tested via PCR with MsSCP-2 gene
specific primers to verify the RNA samples were free of
genomic DNA. Reverse transcription was performed
using 0.5 μg DNA-free total RNA and a Reverse Tran-
scription Kit (Invitrogen, USA). Two microliters of the
first strand cDNA (equivalent to 50 ng total RNA) was
used as a template for MsSCP-x, MsSCP-2 and rpS3
amplification. MsSCP-2 gene-specific forward (MsSCP-
CF2) and reverse primers (MsSCP-CR2) were used for
the PCR reaction (the expected PCR product was 210
bps; Fig. 1). To detect the MsSCP-x transcript, primers
corresponding to the partial sequence of the 2/3-oxoacyl-
CoA thiolase domain (forward primer: xNF; reverse
primer: MsSCP-CR4) were used for the PCR reaction
(the expected PCR product was 151 bps; Fig. 1). Ribo-
somal protein S3 (rpS3) cDNA fragment was amplified
with rpS3-F (5'-TTA ATT CCG AGC ACT CCT TG-3')
and rpS3-R (5'-GGA GCT GTA CGC TGA GAA AG-3')
primers [51] as an internal control. PCR reactions for
MsSCP-2 and MsSCP-x gene amplification were per-
formed as follows: initial denaturing at 95°C for 3 min-
utes, followed by 30 cycles of denaturing at 94°C for 30
seconds, annealing at 61°C for 30 seconds, and extension
at 72°C for 30 seconds with a final extension of 72°C for 2
minutes. PCR control reaction for ribosomal protein S3
(rpS3) was performed as follows: initial denaturing at
95°C for 3 minutes, followed by 30 cycles of denaturing at
94°C for 30 seconds, annealing at 50°C for 30 seconds,
and extension at 72°C for 60 seconds with a final exten-
sion of 72°C for 2 minutes. The PCR products were sepa-
rated on 1% agarose gel.
Western blotting analysis of MsSCP-2 expression
Day 1 5th instars were chilled in ice water for 10 minutes;
tissues were dissected out in cold Manduca saline solu-
tion [50] under a dissecting microscope. Isolated tissues
were homogenized in Manduca saline solution contain-
ing a 0.5 mM benzamidine hydrochloride, 2 mM EDTA,
0.5 mM phenylmethylsulfonyl fluoride, 0.1 mM glutathi-
one, and 0.1 mM protease inhibitor cocktail (Sigma).
Concentrations of soluble proteins in each tissue sample
were determined using a BCA Protein Assay Kit (Pierce,
Rockford, IL, USA).
Proteins (20 μg) from each sample were resolved on a 4-
20% pre-casted gradient SDS PAGE gel (ISC Bioexpress,
Kaysville, UT, USA) and transferred onto a Hybond-C
extra membrane (Amersham BioScience, Piscataway, NJ,
USA) at 18 volts overnight in Tris-glycine transfer buffer
(0.303% Tris base, 1.44% glycine, 20% methanol) as
described [52]. The membrane was incubated for 1 hour
in a blocking solution (5% BSA, 5% normal goat serum,
0.5% Tween-20 in phosphate saline buffer (PBST), pH7.4)
at room temperature, and affinity purified polyclonal
anti-SCP-2 domain of AeSCP-x [18] (1:3000 dilution) was
added into the blocking solution and incubated another 1
hour. After 4 washes of 15 minutes each with PBST, the
blot was incubated with AP (alkaline phophatase)-conju-
gated goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories, INC., West Grove, PA, USA) at a 1:2000
dilution in PBST for 1 hour at room temperature. After 4
washes of 15 minutes each with PBST, alkaline phosphate
substrate solution (100 mM Tris-Cl pH 9.5, 100 mM
NaCl, 5 mM MgCl2, with 33 μl of NBT and 17 μl of BCIP
in 5 ml of solution) was used to visualize the secondary
bound antibodies, which were developed within 30 min-
utes at room temperature.
Ligand and SCPIs binding in MsSCP-2
MsSCP-2 binding affinity for NBD-cholesterol, an analog
of cholesterol, was determined using NBD-cholesterol
binding assays. A 1 ml sample of 10 μM recombinant
MsSCP-2 was diluted with 10 mM KHPO4 buffer (pH 7.4)
to various concentrations (1 nM~10 μM). Twenty-five
microliters of each concentration of MsSCP-2 solution
and the control (without MsSCP-2) were thoroughly
mixed with 25 μl of NBD-cholesterol solution (1 μM in
KHPO4 buffer, pH 7.4) and allowed to equilibrate for 3
minutes to permit stable measurement of the fluores-
cence signal. NBD-cholesterol fluorescence was excited
at 470 nm, and emission was recorded at 530 nm using a
fluorescence microplate reader (Model: GeminiXPS,
Molecular Devices). Data were fit using a simple, single
binding site, non-linear regression model in GraphPad
PRISM® software version 4.0 (GraphPad Software Inc.,
San Diego, CA) using the equation:
Where, Kd is the binding affinity, X is the NBD-choles-
terol concentration (μM), Y is the total binding (fluores-
Y
Bmax X
d X
=
×
+ KKim and Lan BMC Physiology 2010, 10:9
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cent intensity unit), and Bmax is the maximum specific
binding to be fit. AeSCP-2 and GST were used as a posi-
tive control and a negative control, respectively. NBD-
cholesterol binding assays for the controls were per-
formed the same as described above for recombinant
MsSCP-2.
The inhibitory effect of SCPI on cholesterol binding to
MsSCP-2 was measured using NBD-cholesterol competi-
tion assays. In a 50 μl reaction solution in each well of a
96-well plate purified recombinant MsSCP-2 (5 μM) was
incubated with NBD-cholesterol (1.25 μM) in the pres-
ence of increased concentrations of a SCPI (0-12.5 μM) in
10 mM KHPO4 buffer (pH 7.4) for 5 min. The fluores-
cence intensity (excitation/emission = 470/530) of NBD-
cholesterol was measured. The background control was
NBD-cholesterol alone in 10 mM KHPO4 buffer (pH 7.4).
A separate set of tests was performed using NBD-choles-
terol with increasing concentrations of a SCPI to assess
whether a SCPI interfered with NBD-cholesterol fluores-
cence. If a SCPI interfered with NBD-cholesterol fluores-
cence, the background control was NBD-cholesterol
along with the SCPI. The net change in NBD-cholesterol
fluorescence intensity was calculated by subtracting the
fluorescence of the background control from the NBD-
cholesterol-MsSCP-2 complex in the absence or presence
of an inhibitor. The data were plotted with the relative
NBD-cholesterol fluorescent intensity (bound NBD-cho-
lesterol) as the y-axis and the molarities of the inhibitor
as the x-axis. Bacterial GST protein and Aedes aegypti
SCP-2 protein (AeSCP-2) were used as a negative control
and a positive control for the assays, respectively.
Effects of SCPIs on lipids uptake
To examine the effect of SCPIs on lipid absorption/traf-
ficking (label/chase), gate II third day 4th instar M. sexta
were fasted for 2 hr, and then were fed a small piece of
diet (0.1 g) containing SCPIs at LD50 dosage [34] in 2 μl of
ethanol and [3H]-cholesterol (0.033 μCi/ml ethanol) or 2
ul of [3H]-palmatic acid. For the control group, a small
piece of diet (0.1 g) containing only 2 μl of ethanol and
[3H]-cholesterol (0.033 μCi/ml ethanol) or [3H]-palmatic
acid was provided to the larvae. Larvae that consumed
the diet completely within 30 minutes were selected for
the following experiments in three groups (control, SCPI-
1 and SCPI-2) of 6 insects (2 insects/time). From the con-
trol and treated groups, hemolymph, the midgut tissue,
the fat body, and feces from each individual larva were
collected at 2, 4 and 6 hr after feeding. The larvae were
anesthetized on ice for 5 minutes, the hemolymph was
collected via a small cut at the base of the horn and the
hemolymph was bled into a clear test tube by gently
pressing the larvae body. The entire midgut was dissected
out in cold Manduca saline solution [50] containing 0.5
mM benzamidine hydrochloride, 2 mM EDTA, 0.5 mM
phenylmethylsulfonyl fluoride, 0.1 mM glutathione, and
0.1 mM protease inhibitors cocktail (Sigma). The dis-
sected midgut was washed in cold PBS to clean off the
food content. The fat body was carefully dissected and
washed extensively with cold PBS buffer. Collected tissue
samples were stored at -80°C. Frozen samples were
thawed and homogenized with micropestle in 1 ml of n-
hexane:2-propanol (v:v 3:2). Total lipids including [3H]-
cholesterol or [3H]-palmatic acid were extracted from the
midgut, hemolymph, fat body, and feces, using 1 ml of n-
hexane:2-propanol (v:v 3:2). Extracts were centrifuged at
2500 rpm to pellet the denatured protein and other cellu-
lar debris. The organic phase containing [3H]-lipid was
decanted and air dried, then the radioactivity was mea-
sured in a 5 ml high flash-point LSC-cocktail (PerkinEl-
mer, Waltham, MA) using a liquid scintillation analyzer
TriCarb 2500TR (Packard, Meriden, CT, USA). The
denatured protein pellet was dried overnight at room
temperature to evaporate the residual organic solvent.
The dried protein from the extracts was dissolved over-
night in 0.2 M KOH at 65°C and the protein concentra-
tion was determined using a BCA Protein Assay Kit
(Pierce, Rockford, IL). For the tissue samples, radioactiv-
ity and protein content were quantified and expressed as
[3H]-lipid (DPM)/mg soluble protein. For the feces sam-
ple, the total radioactivity was directly quantified.
Statistics
Data were analyzed with two-way ANOVA (GLM proce-
dure) to determine if the control group and SCPIs treated
groups differed significantly . Student t-test was used in
cases where a pair of treatments was compared to deter-
mine the significance of the differences [53].
Additional material
Abbreviations
NBD cholesterol: 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-
5-cholen-3β-ol; SCP-x: sterol carrier protein 2/3-oxyacyl-CoA thiolase; SCP-2:
sterol carrier protein-2; SCPI: sterol carrier protein-2 inhibitor; Lp: lipophorin.
Additional file 1 Effects of SCPIs on [1,2-3H (N)]-cholesterol and [9,10-
3H]-palmitic acid excretion in M. sexta Day 3 4th instar larvae. Feces 
were collected during the experiment time period and processed to mea-
sure total amount of labeled lipids. (A) [3H]-Cholesterol. (B) [3H]-palmatic 
acid. Values = mean ± S.D. (N = 2). Details of the label/chase experiment are 
provided in the "Materials and Methods". The same letters above the bars in 
each time point represent that the mean values did not differ from other 
group of the same time point significantly (p > 0.05) in paired t-tests.
Additional file 2 Dietary uptake of NBD-cholesterol. NBD-cholesterol 
and the SCPI were added into the diet and fed to Day 3 4th instar larvae (12 
insects (4 insects/time)/group) as described for [3H]-cholesterol. Total lipids 
were extracted from tissue samples as described for [3H]-cholesterol. Dried 
lipids were re-dissolved in 50 μl methanol and the NBD fluorescent was 
measured (470/530 nm = excitation/emission). RFU = the relative fluores-
cent unit (sample FU - blank FU).Kim and Lan BMC Physiology 2010, 10:9
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